Boston, MA -- (SBWIRE) -- 03/12/2014 -- Global Market Direct's pharmaceuticals report, "Lightlake Therapeutics Inc. - Product Pipeline Review - 2014" provides data on the Lightlake Therapeutics Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Lightlake Therapeutics Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Lightlake Therapeutics Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Report Scope

- Lightlake Therapeutics Inc. - Brief Lightlake Therapeutics Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Lightlake Therapeutics Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Lightlake Therapeutics Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Lightlake Therapeutics Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get this Report

- Evaluate Lightlake Therapeutics Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Lightlake Therapeutics Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Lightlake Therapeutics Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Lightlake Therapeutics Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Lightlake Therapeutics Inc. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Isarna Therapeutics GmbH - Product Pipeline Review - 2014
- Lightlake Therapeutics Inc. - Product Pipeline Review - 2013
- Antisense Therapeutics Limited - Product Pipeline Review - 2014
- MabVax Therapeutics, Inc. - Product Pipeline Review - 2014
- Allergy Therapeutics plc - Product Pipeline Review - 2014
- Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2014
- Bone Marrow Transplantation - Pipeline Review, H1 2014
- Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2014
- Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Review, H1 2014
- Genzyme Corporation - Product Pipeline Review - 2014